[ Price : $8.95]
FDA says it may approve returning ranitidine-containing products to the market based on new CDER research into the carcinogen NDMA...[ Price : $8.95]
A recent inspection at Dr. Reddys Laboratories active pharmaceutical ingredient manufacturing plant in Middleburg, NY cites three ...[ Price : $8.95]
FDA says it now recommends that people in seven high-risk categories refrain from exposure to dental mercury amalgam when possible...[ Price : $8.95]
Sandoz agrees to pay a $195 million criminal penalty under a deferred prosecution agreement in an ongoing generic drug price-fixin...[ Price : $8.95]
FDAs Immunology Devices Panel of the Medical Devices Advisory Committee recommends that FDA should require dentists to move away f...[ Price : $8.95]
FDA says it is continuing to test ranitidine products from multiple manufacturers and is assessing the potential impact on patient...[ Price : $8.95]
FDA says it will require a new Warning and other steps to inform patients and healthcare professionals about the risk of gadoliniu...